topSkip to main content

Menu, Secondary

Menu Trigger


Harvard University

Last week, Harvard University President Lawrence S. Bacow, Massachusetts Institute of Technology President L. Rafael Reif, and Stanford University President Marc Tessier-Lavigne wrote an op-ed to outline the importance of “drastic action” to protect the health of our nation, including the efforts of America’s leading research universities.
Tumors called high-grade gliomas wire themselves into the healthy brain, receiving and interpreting electrical signals from normal neurons, a study from Stanford, Harvard, MIT, JHU, and the University of Michigan study has found.
A new study from the University of Southern California shows women in their 70s and 80s who were exposed to fine particle pollution had declines in memory and physical brain changes that were not seen in women who breathed cleaner air.
A research team from Stony Brook University and Harvard University showed that humans have significantly altered the brains of different lineages of domestic dogs in different ways through selective breeding
Princeton University scientists, working with a Harvard graduate student, is for the first time applying deep learning — a powerful new version of the machine learning form of AI — to forecast sudden disruptions that can halt fusion reactions and damage the doughnut-shaped tokamaks that house the reactions.
Overlapping surgeries, in which more than one doctor performs sequential surgeries in different operating rooms, carry no greater risk for low-risk, noncardiac patients, a new analysis shows.
A new study suggests that, although they experience them differently, the sighted and the blind are still able to share a common understanding of abstract visual phenomena like rainbows and color.
Studies demonstrate for the first time that sustained smoking cessation can reduce the risk of developing seropositive rheumatoid arthritis (RA), the more severe form of the disease.
The ability to do 40-plus pushups can be a no-cost method to determine the risk of cardiovascular disease, according to a study from the Harvard Chan School.
Researchers have created a drug-free, reversible antiplatelet therapy that employs deactivated “decoy” platelets that could reduce the risk of blood clots and potentially prevent cancer metastasis as well.